# Xunming Shengke raises USD 100 million in Series B funding, bringing total funding close to USD 200 million

On 2026/8/11, Elsewhere reported that Chinese biological AI company Xunming Shengke raised USD 100 million in Series B funding, bringing total funding close to USD 200 million. The round was completed in stages, with proceeds supporting biological foundation model R&D and training at scale.



Canonical: https://uniquebase.ai/news/3cf52c95-d578-4c3c-ad48-9b19ff63a715
Stable identifier: 3cf52c95-d578-4c3c-ad48-9b19ff63a715
Snapshot captured: 2026-10-20T18:19:32.670Z
English updated: 2026-10-20T18:31:08.162Z

## Connected profiles

- [Aureka Biotechnologies](/companies/aureka-biotechnologies)
- [Granite Asia](/institutions/granite-asia)
- [Honghui Fund](/institutions/honghui-fund)
- [Jingwei Venture Capital](/institutions/jingwei-venture-capital)
- [Niuerli Capital](/institutions/niuerli-capital)
- [Qiming Venture Capital](/institutions/qiming-venture-capital)

## Sources

- https://elsewhere.news/zh/5ycapital/1bai-5y-news